Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Boston Therapeutics to initiate Phase II clinical study of BTI-320 in U.S.
Boston Therapeutics to initiate Phase II clinical study of BTI-320 in U.S.
Boston Therapeutics to initiate Phase II clinical study of BTI-320 in U.S.
Submitted by
admin
on March 4, 2014 - 9:18am
Source:
The Fly on the Wall
News Tags:
Boston Therapeutics
BTI-320
diabetes
Headline:
Boston Therapeutics to initiate Phase II clinical study of BTI-320 in U.S.
Do Not Allow Advertisers to Use My Personal information
